Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus sevoflurane anesthesia and plasma exosome function in radical gastrectomy
ChiCTR1900023034Phase 4Not yet recruiting
- Sponsor
- Harbin Medical University Cancer Hospital
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and sevoflurane in gastric cancer (GC) (2 arms), sponsored by Harbin Medical University Cancer Hospital. Primary endpoint: Plasma exosomes. Planned start May 2019; status: not yet recruiting.
02
Drugs
propofolsevoflurane
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR1900023034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023034.